BIS
ETF / Mutual Fund
NASDAQ
ProShares UltraShort Nasdaq Biotechnology
$17.94
-$0.11 (-0.62%)
Price Chart
Overview
About BIS
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the Daily Target. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
AUM
Volume
254.0K
Avg. Volume
239.2K
Expense Ratio
0.90%
Fund Information
Exchange
NASDAQ
Sector
Risk & Correlation Analysis
Market Correlation
-1.66
Inversely Correlated
Volatility
Medium (0.36)
Relative to market
Macro Factor Sensitivities
Interest Rates
Medium Sensitivity
Inflation
Medium Sensitivity
GDP Growth
Low Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, BIS shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
AUM
Volume254.0K
Expense Ratio0.90%
Important Dates
Next Dividend
Next Earnings
Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025